1. , , , . In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry. 1995;52:145–53.
2. , , , Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry. 1992;49:651–68.
3. , , , et al. Sleep in schizophrenia: A polysomnographic study on drug-naïve patients. Neuropsychopharmacology. 1997;16:51–60.
4. , , , . Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry. 1991;30:904–12.
5. , , , et al. Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry. 1992;49:185–94.
6. , , , . A longitudinal study of EEG sleep in schizophrenia. Psychiatry Res. 1996;59:203–11.
7. , , , et al. Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients. J Clin Psychopharmacol. 2007;27:703–5.
8. , , , et al. Delta power in sleep in relation to neuropsychological performance in healthy subjects and schizophrenia patients. J Neuropsychiatry Clin Neurosci. 2006;18:529–35.
9. , , , et al. Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia. J Psychiatr Res. 2004;38:591–9.
10. , , , et al. Attention and non-REM sleep in neuroleptic-naive persons with schizophrenia and control participants. Psychiatry Res. 2007;149:33–40.
11. , , , et al. Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry. 1999;45:1426–32.
12. . Schizophrenia. N Engl J Med. 2003;349:1738–49.
13. , . Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl). 1996;124:2–34.
14. , , , et al. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res. 1999;35:369–82.
15. , . Dose effects of chlorpromazine on human sleep. Psychopharmacologia. 1969;14:342–8.
16. , , , . Chlorpromazine and human sleep. Psychopharmacologia. 1971;20:280–7.
17. , , , . Chlorpromazine and sleep in psychiatric patients. Arch Gen Psychiatry. 1971;24:185–9.
18. , , , et al. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Arch Gen Psychiatry. 1974;31:62–6.
19. , , , et al. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers. Psychopharmacology (Berl). 2007;190:507–16.
20. , , , et al. Sawtooth waves during REM sleep after administration of haloperidol combined with total sleep deprivation in healthy young subjects. Braz J Med Biol Res. 2002;35:599–604.
21. , , , . The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res. 1996;30:411–19.
22. , , , et al. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry. 2000;33:109–11.
23. , , , et al. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry. 1997;42:260–6.
24. , , . Dosing atypical antipsychotics. CNS Spectr. 2008;5 (Suppl 9):1–16.
25. , , , et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res. 2002;109:137–42.
26. , , , et al. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007;22:299–308.
27. , , . Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry. 2000;47:468–70.
28. , , , et al. Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol. 2002;17:177–84.
29. , , , et al. Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment. J Psychopharmacol. 2006;20:80–5.
30. , , , et al. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin. 2004;56:345–50.
31. , , , et al. Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry. 2004;37:157–62.
32. , , , . Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry. 1999;46:141–3.
33. , , , et al. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry. 2005;66:989–96.
34. , , , et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl). 2004;174:421–9.
35. , , , et al. Psychopharmacology (Berl). 2008;196:337–8.
36. , , . Medication-induced somnambulism in a patient with schizoaffective disorder. J Clin Psychiatry. 1986;47:523–4.
37. , . Somnambulism induced by quetiapine: two case reports and a review of the literature CNS. Spectr. 2007;12:910–12.
38. , , . Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:581–2.
39. , , . Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999;19:478–9.
40. , , . Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35:109–11.
41. , , , et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008;43:70–5.
42. , , , et al. Epidemiology, implications and mechanisms underlying drug-induced weigh gain in psychiatric patients. J Psychiatr Res. 2003;37:193–220.